Viewing Study NCT02923466


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-02-22 @ 6:44 PM
Study NCT ID: NCT02923466
Status: COMPLETED
Last Update Posted: 2022-04-27
First Post: 2016-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Sponsor: Vyriad, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Solid Tumour View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory solid tumor View